Niftify.in: Live Stock Market Data, Stock News, Analysis & Investing in India

fintech Industry News

Get all the latest fintech industry, fintech stocks, and fintech market news in on one place.

Stocks News

VCs happy with returns as early backers offload 10% stake in Honasa Consumer: Varun Alagh

According to the bulk deal data available on the National Stock Exchange (NSE), Peak XV Partners sold a 3.81% stake in Honasa Consumer and Fireside Ventures offloaded a 2.03% stake in the company.

HONASA

Best option is to double down on market strategy, says P&G India

On the PGHH call, Mrinalini Srinivasan, CFO, said that positive trends are finally emerging in the Indian fast-moving consumer goods (FMCG) industry, both in urban and rural areas

PGHH

URBAN

Sebi remains bullish on Reit market in India, says WTM Ashwani Bhatia

WTM Ashwani Bhatia says benchmarking to bring accuracy, efficiency, and more customers into its fold

ACCURACY

NTPC Green Energy files draft papers for Rs 10,000 crore IPO

NTPC Green Energy has filed draft papers for a 100 billion rupees initial public offering, aiming to benefit from India's renewables expansion and a strong equities market. The company will issue new shares, with no existing shareholders selling stakes. This move aligns with India's goal to add 500 GW of clean energy by 2030.

NTPC

CLEAN

VCs happy with returns as early backers offload 10% stake in Honasa Consumer: Varun Alagh

According to the bulk deal data available on the National Stock Exchange (NSE), Peak XV Partners sold a 3.81% stake in Honasa Consumer and Fireside Ventures offloaded a 2.03% stake in the company.

HONASA

GRSE wins order for multi-purpose vessels of 7500 DWT

GRSE

ICICI Bank stock hits record high, market cap crosses ₹9 lakh crore for first time; What's driving the rally?

On September 18, ICICI Bank stock reached an all-time high of ₹1,295 on the BSE, marking a 2 percent increase from the previous close, with a market capitalization of ₹9.1 lakh crore.

ICICIBANK

BSE

ZEEL refutes Disney Star's $940 mn damages over failed ICC TV rights deal

ZEEL's stock fell 1.35 per cent to Rs 131.20 a piece on NSE

ZEEL

STAR

Heritage Foods to set up ₹204-cr ice cream factory in Telangana; stocks trade flat

Company seeks to increase production, meet growing regional demand for ice cream

HERITGFOOD

Stock market update: FMCG stocks down as market falls

The 30-share BSE Sensex closed down 131.43 points at 82948.23

BSE

Lupin, Takeda in pact to market gastric drug in India; stock slips.

Lupin to market Takeda’s Vonoprazan tablets in India under brand name Lupivon

LUPIN

Stock market today: Nifty 50, Sensex slide in choppy trade, IT stocks plummet

The Nifty 50 ended the session with a 0.16 per cent drop at 25,377 points. Likewise, S&P BSE Sensex has also concluded the trade at 82,968 points, a 0.13 per cent lower as compared to the previous close.

BSE

Multibaggers: 11 stocks gain over 20% in each of the Oct-Dec quarters for the last 4 years

An ETMarkets study revealed 11 stocks listed on the BSE that have consistently gained more than 20% in every October-December quarter over the past four years.

BSE

Motisons up 12% ahead of board meet for stock split; zooms 101% in 31 days

The meeting of the board of directors of the company will be held on Thursday, September 19, 2024, to consider the proposal for sub-division/split of equity shares

MOTISONS

VCs happy with returns as early backers offload 10% stake in Honasa Consumer: Varun Alagh

According to the bulk deal data available on the National Stock Exchange (NSE), Peak XV Partners sold a 3.81% stake in Honasa Consumer and Fireside Ventures offloaded a 2.03% stake in the company.

HONASA

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India

Lupin announced that it has entered into a non-exclusive patent license agreement with Takeda Pharmaceutical Company (Takeda), to commercialize Vonoprazan Tablets in the Indian market.

LUPIN

Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market

Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The drug, approved for various gastrointestinal conditions, will be marketed as Lupivon in 10 mg and 20 mg strengths. This agreement aims to enhance Lupin's gastroenterology portfolio and address unmet patient needs.

LUPIN

Mphasis shares drop 6.17% as Sensex falls

The stock quoted a 52-week high of Rs 3186.95 and a 52-week low of Rs 2068.45.

MPHASIS

Share price of LTIMindtree falls as Nifty weakens

A total of 9,292 shares changed hands on the counter till 02:04PM (IST).